IL153532A0 - Process for the preparation of pyrazolopyrimidinones - Google Patents

Process for the preparation of pyrazolopyrimidinones

Info

Publication number
IL153532A0
IL153532A0 IL15353201A IL15353201A IL153532A0 IL 153532 A0 IL153532 A0 IL 153532A0 IL 15353201 A IL15353201 A IL 15353201A IL 15353201 A IL15353201 A IL 15353201A IL 153532 A0 IL153532 A0 IL 153532A0
Authority
IL
Israel
Prior art keywords
pyrazolopyrimidinones
preparation
Prior art date
Application number
IL15353201A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL153532(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015472A external-priority patent/GB0015472D0/en
Priority claimed from GB0105857A external-priority patent/GB0105857D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of IL153532A0 publication Critical patent/IL153532A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15353201A 2000-06-22 2001-06-11 Process for the preparation of pyrazolopyrimidinones IL153532A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0015472A GB0015472D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105857A GB0105857D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazolopyrimidinones
PCT/IB2001/001050 WO2001098284A1 (en) 2000-06-22 2001-06-11 Process for the preparation of pyrazolopyrimidinones

Publications (1)

Publication Number Publication Date
IL153532A0 true IL153532A0 (en) 2003-07-06

Family

ID=26244540

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15353201A IL153532A0 (en) 2000-06-22 2001-06-11 Process for the preparation of pyrazolopyrimidinones

Country Status (28)

Country Link
EP (1) EP1292586B1 (pl)
JP (1) JP2004501142A (pl)
KR (1) KR100525698B1 (pl)
CN (1) CN100338047C (pl)
AP (1) AP2001002194A0 (pl)
AR (1) AR028740A1 (pl)
AT (1) ATE272626T1 (pl)
AU (2) AU6259701A (pl)
BR (1) BR0111581A (pl)
CA (1) CA2411961C (pl)
CZ (1) CZ20024176A3 (pl)
DE (1) DE60104691T2 (pl)
DK (1) DK1292586T3 (pl)
DO (1) DOP2001000190A (pl)
ES (1) ES2223863T3 (pl)
HU (1) HUP0301183A3 (pl)
IL (1) IL153532A0 (pl)
MX (1) MXPA02012884A (pl)
MY (1) MY124903A (pl)
PA (1) PA8519801A1 (pl)
PE (1) PE20020105A1 (pl)
PL (1) PL359651A1 (pl)
PT (1) PT1292586E (pl)
SV (1) SV2002000503A (pl)
TN (1) TNSN01093A1 (pl)
TR (1) TR200401983T4 (pl)
WO (1) WO2001098284A1 (pl)
YU (1) YU93902A (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) * 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
EP2228370B1 (en) * 2007-12-28 2012-05-23 Topharman Shanghai Co., Ltd. N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
WO2011016016A1 (en) 2009-08-07 2011-02-10 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
JP2013517281A (ja) * 2010-01-13 2013-05-16 テンペロ、ファーマシューティカルズ、インコーポレイテッド 化合物及び方法
MX2010006227A (es) 2010-06-07 2011-12-14 World Trade Imp Exp Wtie Ag Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
FR2970967B1 (fr) 2011-01-27 2013-02-15 Pf Medicament Derives de type azaindazole ou diazaindazole comme medicament
EP2689778A1 (en) 2012-07-27 2014-01-29 Pierre Fabre Medicament Derivatives of azaindoles or diazaindoles for treating pain
EP2689779A1 (en) 2012-07-27 2014-01-29 Pierre Fabre Medicament Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk
PL3529246T3 (pl) * 2016-10-24 2024-03-25 Fmc Corporation Oksadiazole o działaniu grzybobójczym
JP2022501410A (ja) * 2018-10-01 2022-01-06 ピーアイ インダストリーズ リミテッドPi Industries Ltd 新規なオキサジアゾール

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
EP1002798A1 (en) * 1998-11-20 2000-05-24 Orchid Chemicals & Pharmaceuticals Ltd. An improved process for preparing a therapeutically active pyrazolopyrimidinone derivative

Also Published As

Publication number Publication date
CA2411961C (en) 2007-02-06
ES2223863T3 (es) 2005-03-01
MXPA02012884A (es) 2003-05-14
CA2411961A1 (en) 2001-12-27
PE20020105A1 (es) 2002-02-21
KR20030031912A (ko) 2003-04-23
TR200401983T4 (tr) 2004-09-21
DK1292586T3 (da) 2004-08-30
AP2001002194A0 (en) 2002-12-21
CN1437589A (zh) 2003-08-20
SV2002000503A (es) 2002-07-03
DE60104691T2 (de) 2005-01-13
HK1054926A1 (en) 2003-12-19
DE60104691D1 (de) 2004-09-09
EP1292586A1 (en) 2003-03-19
EP1292586B1 (en) 2004-08-04
CN100338047C (zh) 2007-09-19
BR0111581A (pt) 2003-03-25
PT1292586E (pt) 2004-11-30
AU6259701A (en) 2002-01-02
JP2004501142A (ja) 2004-01-15
YU93902A (sh) 2005-11-28
HUP0301183A2 (hu) 2003-08-28
ATE272626T1 (de) 2004-08-15
MY124903A (en) 2006-07-31
HUP0301183A3 (en) 2006-02-28
WO2001098284A1 (en) 2001-12-27
AR028740A1 (es) 2003-05-21
KR100525698B1 (ko) 2005-11-03
AU2001262597B2 (en) 2005-10-20
TNSN01093A1 (fr) 2005-11-10
DOP2001000190A (es) 2002-05-15
PL359651A1 (pl) 2004-08-23
CZ20024176A3 (cs) 2004-01-14
PA8519801A1 (es) 2002-04-25

Similar Documents

Publication Publication Date Title
HU0103291D0 (en) Process for the preparation of citalopram
IL155177A0 (en) Method for the preparation of grf-peg conjugate
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
GB2360517B (en) An improved process for the preparation of arteethers from dihydroartemisinin
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
HUP0301183A3 (en) Process for the preparation of pyrazolopyrimidinones
HUP0302594A3 (en) Process for the preparation of phenethylamine derivatives
AU8824201A (en) Process for the preparation of dinapsoline
EP1300382A4 (en) PROCESS FOR PREPARING LOWER OLEFINS
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
SI1127876T1 (en) Process for the preparation of isoindoline
AU6259201A (en) Novel process for the preparation of pyrazolopyrimidinones
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
GB0015462D0 (en) Novel process for the preparation of pyrazolopyrimidinones
PL368905A1 (pl) Sposób otrzymywania beta-jonylidenoacetaldehydu
SI1292586T1 (en) Process for the preparation of pyrazolopyrimidinones
GB0015472D0 (en) Novel process for the preparation of pyrazolopyrimidinones
SI1296983T1 (en) Novel process for the preparation of pyrazolopyrimidinones
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
HU0003616D0 (en) Process for the preparation of pyridyl-ketone
GB0028881D0 (en) Process for the preparation of endo-5-norbornene-2-ol